Gynecological endocrinology in age aspect: problems and decisions

Russian scientific and practical conference

31 October – 3 November, 2017
Research Center for Gynecology and Perinatology, 4, ak. Oparina street, Moscow, Russia


  • The Ministry of Health of the Russian Federation
  • Federal State Budget Institution Scientific Center for Obstetrics, gynecology and perinatology
  • Russian Society of Obstetricians and Gynecology
  • Russian Association of Gynecologists and Endocrinologists
  • Russian Association of menopause
  • Congress operator LLC "MEDI Expo"


The conference will be attended by the obstetricians-gynecologists, gynecologists-endocrinologists, endocrinologists, cardiologists, gerontologists, urologists and other specialists in related professions from all regions of Russia (over 500 people).

The conference will be held with the participation of leading Russian specialists in the field of gynecological endocrinology with the invited of international experts.

Leaders of conference

Chernukha G.E.
Head of the Department of Gynecological endocrinology of the Research Center for Gynecology and Perinatology of the Ministry of Health of Russia

Scientific program

The following key issues of women's health at different stages of reproductive aging will be discussed at the conference:

  • Molecular genetic, epigenetic, and immunological reasons of the reproductive system function impairment
  • Determination of the women's reproductive system aging stages (STRAW+10 criteria) as the basis for the modern gynecological practice
  • Genomic and non-genomic effects of endo- and exogenous sex hormones
  • Cell technologies in gynecology
  • Uterine bleeding in the context of modern drug therapy opportunities and latest recommendations
  • Diagnosis of hyper- and androgen deficiency conditions and their correction
  • Polycystic ovary syndrome: preservation of the reproductive function and health
  • Impaired fat metabolism, metabolic syndrome and reproductive function
  • Endocrinologic aspects of hormonal contraception
  • Expansion of use of long-acting reversible contraceptives (LARC): global trend
  • A "niche" of GnRH agonists/antagonists and sex hormones in gynecology
  • Innovative therapies of uterine fibroids
  • Endometriosis as a chronic inflammatory disease and principles of drug therapy
  • The treatment of hyperplastic endometrial processes in view of recent recommendations
  • Combined uterus pathology (uterine fibroids, adenomyosis, endometrial hyperplasia): focus on the uterus sparing
  • Postmenopausal osteoporosis (therapeutic approaches)
  • The role of hormones and metabolic disorders in the genesis of age-related osteoarthritis
  • Genitourinary syndrome
  • Gender differences in risk factors, course, and prevention of cardiovascular diseases: opportunities of MHT in view of recent evidence-based studies
  • Menopause follow-up and MHT issues: consensus of the world's leading organizations
  • MHT and gynecologic cancers
  • Systemic MHT after preventive surgeries in BRCA gene mutation carriers
  • The efficacy and safety of alternative therapy of menopausal disorders (SERM, TSEK, SSRI, SNRI, phytoestrogens, etc.)
  • Various aspects of healthy aging and the role of a gynecologist

Specialized exhibition

The Conference will be held an exhibition, where leading companies manufacturers of drugs and medical equipment will present their latest developments.